Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit

Acute generalized exanthematous pustulosis (AGEP) is an exanthematous condition, predominantly occurring as a result of drug reactions. We, hereby, present the first case of AGEP following treatment with remdesivir in a patient with COVID-19, without hydroxychloroquine use, which serves as a reminde...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohaghegh, Fatemeh, Hatami, Parvaneh, Aryanian, Zeinab, Fatemi, Farahnaz, Mohseni Afshar, Zeinab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385380/
https://www.ncbi.nlm.nih.gov/pubmed/35991338
http://dx.doi.org/10.1155/2022/9880827
Descripción
Sumario:Acute generalized exanthematous pustulosis (AGEP) is an exanthematous condition, predominantly occurring as a result of drug reactions. We, hereby, present the first case of AGEP following treatment with remdesivir in a patient with COVID-19, without hydroxychloroquine use, which serves as a reminder to consider remdesivir as a possible causative agent when dealing with AGEP presentation in COVID patients.

Ejemplares similares